JAGX 8-K 2026-09-25
Jaguar Health, Inc. (JAGX) 8-K dated 2026-09-25 — accession 0001193125-26-401239.
Jaguar Health, Inc. (JAGX) is a biotechnology company listed on NASDAQ.
Jaguar Health, Inc. filed a 8-K on 2026-09-25. Accession 0001193125-26-401239.
This 8-K covers: Material agreement (Item 1.01), Agreement ended (Item 1.02), Unregistered share sale (Item 3.02), Other events (Item 8.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported JAGX revenue for 2025-12-31 was $11.5M. Net income was -$53.6M. Revenue was down 1.5% from 2024-12-31 to 2025-12-31. JAGX currently screens at market cap $1.7M.
Not investment advice. The JAGX SEC hub lists recent forms. The stock page is the research view.